Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of molecular diagnostics products and services that are used to diagnose human diseases, screen donated human blood, ensure transplant compatibility, and aid biomedical research. Gen-Probe has nearly three decades of molecular diagnostics expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing molecular assays and systems that help safeguard the blood supply.

May 8, 2012 -FDA Clears Gen-Probe's PANTHER® System for use with APTIMA Combo 2® Assay... more
May 3, 2012 -Gen-Probe Withdraws from Previously Announced Investor Presentations... more

Webcast - Q1 2012 Gen-Probe Earnings and Acquisition Annoucement Conference Call Monday, April 30, 2012 8:15 a.m.. ET ... listen















